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As publications on breast cancer (ranging from basic
science through to results of clinical trials) continue
apace, it is essential that those involved in the field are
made aware of key developments. To facilitate this, Breast
Cancer Research launched a Paper Report service in May
1999. The original format highlighted recent publications
specifically relevant to breast cancer in the form of a short
report. Each report, which was published on our web site,
included a brief description of the research and comments
from the reporter. The reports were based on articles
selected by the reporter from a broad range of journals
covering all areas of science relevant to research in breast
cancer. Since the service began, we have published 188
Paper Reports on our web site (http://breast-cancer-
research.com/reports/browse.asp?sort=paper), with some
key reports additionally printed in the paper version of
Breast Cancer Research.
The service was revised in June 2002, taking advantage of
the web-based literature awareness service, Faculty of
1000 (www.facultyof1000.com). Faculty of 1000 is pro-
vided by BioMed Central and offers scientists a continu-
ously updated insider’s guide to the most important
papers within a chosen field of biological research. Papers
are highlighted and evaluated on the basis of their scien-
tific merit by members of a faculty of over 1400 leading
scientists. By using Faculty of 1000, Breast Cancer
Research eliminated the need for the reporter to compile a
précis of an individual paper. Instead an invited reporter
compiles a short report from a selection of recent Faculty
of 1000 article evaluations relevant to breast cancer,
usually with a related theme. Faculty of 1000’s evaluations
of selected new findings are also provided.
To underline the difference from the old-style paper
reports, Breast Cancer Research has now re-launched the
revised service as Viewpoints, the first of which have
already been published [1–5] and can be found on our
website at http://breast-cancer-research.com/reports/
browse.asp?sort=Viewpoint. All Viewpoint articles are
sent to PubMed/PubMedCentral.
Currently, Faculty of 1000 only provides this service for
biology papers, however a medical service is in the
process of being set up and BioMed Central, the pub-
lisher, anticipates launching it in early 2004. In the mean-
time, new developments in translational and clinical
research into breast cancer will be covered by additional
bimonthly commentaries.
We realise that a service like Faculty of 1000 is not
immune to criticism and there may be cases where some
of our readers do not agree with the selection of papers or
their evaluation. Any selection would be subject to such
criticism and our reporters are free to include other addi-
tional papers of importance in their Viewpoint articles,
wherever suitable.
We anticipate Viewpoints will become a recognised
resource and a key feature of Breast Cancer Research,
highlighting important articles and bringing them to the
attention of the breast cancer community.
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Abstract
Literature awareness is an essential requirement for successful research. Breast Cancer Research has
launched a new Viewpoints section, which replaces the Paper Reports section as a means of
highlighting important research articles relevant to the biology of breast cancer and bringing them to
the attention of the breast cancer community.
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